Genome Insight Funding: $52M Raised, Series B (2023)
Genome Insight is based in San Diego. It has raised $52M in total funding. Latest round: Series B.
Genome Insight funding overview
Genome Insight is based in San Diego. Genome Insight has raised $52M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2023. The round record for Genome Insight runs through 2023; nothing later has been disclosed. Investors on record include Samsung Venture Investment Corporation, Asan Foundation, SCL Group, Ignite Innovation. 4 distinct backers are named across the disclosed rounds.
Genome Insight at a glance
Total raised
$52M
Latest round
Series B
Latest round date
November 2023
Headquarters
San Diego
Notable investors
Samsung Venture Investment Corporation, Asan Foundation, SCL Group, Ignite Innovation
Frequently asked about Genome Insight funding
How much has Genome Insight raised?
Genome Insight has raised $52M in total disclosed funding across the rounds on record.
Who has invested in Genome Insight?
Samsung Venture Investment Corporation, Asan Foundation, SCL Group, Ignite Innovation are named among the investors backing Genome Insight.
What was the latest Genome Insight funding round?
The most recent disclosed round is a Series B, announced in November 2023.
Where is Genome Insight based?
Genome Insight is based in San Diego.
When did Genome Insight last raise?
The last disclosed Genome Insight round closed in November 2023 at Series B.
We update the Genome Insight record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Diego and their backers are listed below.
